Cannabinoid agonists arrest tumor progression in a rodent model of malignant glioma. Will these molecules provide a starting point for new strategies for anti-cancer therapy (313–319)?
This is a preview of subscription content, access via your institution
Access options
Subscribe to Journal
Get full journal access for 1 year
$79.00
only $6.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.

References
Christison, R. in A Dispensatory, or Commentary on the Pharmacopoeias of Great Britain (and the United States) 971–974 (Lea and Blanchard, Philadelphia, 1848).
Adams, R. Marihuana. Harvey Lect. 37, 168 ( 1941).
Gaoni, Y. & Mechoulam, R. Isolation, structure and partial synthesis of an active constituent of hashish. J. Am. Chem. Soc. 86, 1646–1647 ( 1964).
Matsuda, L.A., Lolait, S.J., Brownstein, M.J., Young, A.C. & Bonner, T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561–564 (1990).
Piomelli, D., Beltramo, M., Giuffrida, A. & Stella, N. Endogenous cannabinoid signaling. Neurobiol. Disease, 5 462–473 (1998).
Galve-Roperh, I. et al. Anti-tumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation . Nature Med. 6, 313–319 (2000).
Matsuda, L.A. Molecular aspects of cannabinoid receptors. Critical Rev. Neurobiol. 11, 143–166 ( 1997).
Kolesnick, R.N. & Krönke, M. Regulation of ceramide production and apoptosis. Annu. Rev. Physiol. 60, 643–665 (1998).
Avgeropoulos, N.G. & Batchelor, T.T. New treatment strategies for malignant gliomas. Oncologist 4, 209–224 (1999).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Piomelli, D. Pot of gold for glioma therapy. Nat Med 6, 255–256 (2000). https://doi.org/10.1038/73088
Issue Date:
DOI: https://doi.org/10.1038/73088